drug_type
RELEVANT_DRUG
intervention_type
Biological (therapeutic vaccine/APC-based immunotherapy)
drug_description
A subcutaneous therapeutic vaccine/APC-based immunotherapy naturally loaded with EBV antigens that enhances antigen presentation, activates dendritic cells, and primes EBV-specific CD4+ and CD8+ T cells to mount cytotoxic responses against EBV-positive tumor cells.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_mesh_term
Epstein-Barr Virus Vaccines
drug_category
DC VACCINE
drug_class
Vaccine
drug_delivery_route
Subcutaneous
drug_mechanism_of_action
Autologous APC/dendritic cell–based therapeutic vaccine naturally loaded with EBV antigens that enhances antigen presentation (MHC I/II), activates dendritic cells, and primes EBV‑specific CD4+ and CD8+ T cells to mount cytotoxic responses against EBV‑positive tumor cells.
drug_name
EBV immunological agent
nct_id_drug_ref
NCT05707910